FDA urged to revise contraceptive labels over blood clot risks
CWN - December 09, 2011
A panel that advises the Food and Drug Administration (FDA) is calling upon the agency to revise the labels of Yaz and Yasmin, two popular forms of the birth control pill.
The FDA, which has linked 50 deaths to the drugs, has found that “women taking Yasmin were about twice as likely to develop venous or arterial thrombotic events (VTEs and ATEs) than women on older birth control,” according to Reuters. Bayer, the pills’ maker, is facing 10,000 lawsuits alleging harm caused by the drugs.
In a close 15-11 vote, the panel stated that the benefits of the drugs nonetheless outweigh the risks.
Additional sources for this story
Some links will take you to other sites, in a new window.
|
An appeal from our founder, Dr. Jeffrey Mirus: Dear reader: If you found the information on this page helpful in your pursuit of a better Catholic life, please support our work with a donation. Your donation will help us reach five million Truth-seeking readers worldwide this year. Thank you! |
Easter Campaign: Progress toward our Spring 2013 goal ($32,825 to go):
$80,000.00
$47,174.67
41%
59%
|
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a donor, log in to see the comment form; otherwise please support our work, and Sound Off!
-
Posted by: hartwood01 -
Dec. 13, 2011 4:43 PM ET USA
Many physicians worship at the feet of Pharmacy. You won't find them reluctant to prescribe,especially the latest and greatest,which is introduced with minimal testing to rush to market.
-
Posted by: rpp -
Dec. 10, 2011 7:48 PM ET USA
Any other drug would have been pulled form the market as a consequence of so many deaths.
